Dr. Laura J. Kopplin is Associate Professor of Ophthalmology at the University of Wisconsin-Madison School of Medicine and Public Health. She completed a fellowship in uveitis and ocular immunology at the Casey Eye Institute – Oregon Health & Science University and the Devers Eye Institute in Portland, Oregon. Her research interests include epidemiology and risk factors for inflammatory eye diseases, clinical trials of uveitis therapeutics, biomarkers for uveitis outcomes, and clinical management of ocular inflammatory disease. She is the Subcommittee Chair of the American Academy of Ophthalmology Preferred Practice Pattern – Uveitis Panel. She is also the co-host of Headlight in the Fog: The Uveitis Podcast.Dr. Joanne Valeriano-Marcet is Professor of Medicine at the University of South Florida in Tampa, Florida. She completed her fellowship in rheumatology at Mount Sinai Medical Center. Her awards have included the Parker J. Palmer “Courage to Teach” Award for Program Director Excellence from the ACGME and the Outstanding GME Program Director Award from USF, and she has been named among the Best Doctors in America. She has published widely and served on the ACGME Working Group to develop the Rheumatology Milestones 2.0.

• 1. General overview of the eye in health and in autoimmune disease 2. Approach to the Patient with Ophthalmologic Manifestations of Rheumatic 3. Ocular Manifestations of Rheumatoid Arthritis 4. Ophthalmologic Disease in the ANCA Associated Vasculitides 5. Ophthalmologic Disease in Giant Cell Arteritis, Takayasu arteritis, and other systemic non-ANCA Vasculitides 6. Ophthalmologic Diseases in the Spondyloarthritides 7. Ophthalmic Disease in Sarcoidosis 8. Ophthalmologic Disease in Systemic Lupus Erythematosus and Antiphospholipid Syndrome 9. Ophthalmologic Disease in Behcet Syndrome 10. Ophthalmologic Involvement in Sjögren’s Disease 11. Ophthalmologic Disease in IgG4-Related Disease 12. Ophthalmologic Disease in Cogan Syndrome, Relapsing Polychondritis, VEXAS Syndrome and other disorders 13. Ophthalmologic Disease in Systemic Sclerosis, Polymyositis and Dermatomyositis 14. Inflammatory Ocular Syndromes Without Systemic Associations 15. Considerations for Pediatric Rheumatologic Patients with Ophthalmic Disease 16. Ophthalmologic Side Effects of Rheumatologic Medications 17. Immunosuppressive Therapies for Inflammatory Ocular Disease